Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GW Pharmaceuticals PLC (NASDAQ:GWPH)

93.20
Delayed Data
As of 3:59pm ET
 -1.48 / -1.56%
Today’s Change
35.83
Today|||52-Week Range
120.99
+34.22%
Year-to-Date
3 Reasons Momentum Stock Investors Will Love GW Pharmaceuticals (GWPH)
Jul 22 / Zacks.com - Paid Partner Content
What's in Store for Mead Johnson (MJN) in Q2 Earnings?
Jul 20 / Zacks.com - Paid Partner Content
Zimmer Biomet (ZBH) Q2 Earnings: A Beat in the Cards?
Jul 21 / Zacks.com - Paid Partner Content
Will AmSurg's Merger with Envision Healthcare Drive Growth?
Jul 15 / Zacks.com - Paid Partner Content
GNC Holdings (GNC) Q2 Earnings: Will the Stock Disappoint?
Jul 21 / Zacks.com - Paid Partner Content
Medtronic's IN.PACT Admiral DCB Wins FDA Nod for 150 mm
Jul 15 / Zacks.com - Paid Partner Content
ResMed (RMD) Q4 Earnings: Disappointment in the Cards?
Jul 20 / Zacks.com - Paid Partner Content
Pfizer Publishes Final Data from Atopic Dermatitis Studies
Jul 14 / Zacks.com - Paid Partner Content
Thermo Fisher (TMO) Q2 Earnings: Surprise in Store?
Jul 20 / Zacks.com - Paid Partner Content
Geron (GERN) Gets Three Patents for Imetelstat in the U.S.
Jul 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close94.68
Today’s open94.48
Day’s range92.00 - 94.74
Volume191,801
Average volume (3 months)572,608
Market cap$2.1B
Dividend yield--
Data as of 3:59pm ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)-140.06%
Earnings growth (this year)-60.99%
Earnings growth (next 5 years)-47.44%
Revenue growth (last year)-11.81%
P/E ratio--
Price/Sales42.63
Price/Book5.55

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV+0.11+0.21%
IRWDIronwood Pharmaceuti...-0.20-1.40%
RAREUltragenyx Pharmaceu...+0.49+0.91%
IPXLImpax Laboratories I...+0.21+0.69%
Data as of 3:59pm ET, 07/25/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$1.51
Annual revenue (last year)$44.0M
Annual profit (last year)-$68.7M
Net profit margin-156.14%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Justin D. Gover
Chief Operating Officer &
Executive Director
Christopher John Tovey
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts

Partner Offers

Search for Jobs